Open Access

Mitochondrial gene COX2 methylation and downregulation is a biomarker of aging in heart mesenchymal stem cells

  • Authors:
    • Xiguang Sun
    • Zilong Wang
    • Xiaoqiang Cong
    • Yudan Lv
    • Zhuo Li
    • Li Rong
    • Tianye Yang
    • Dehai Yu
  • View Affiliations

  • Published online on: November 25, 2020     https://doi.org/10.3892/ijmm.2020.4799
  • Pages: 161-170
  • Copyright: © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The mitochondria have been proven to be involved in processes of aging; however, the mechansims through which mitoepigenetics affect the cytological behaviors of cardiomyocytes during the aging process are not yet fully understood. In the present study, two senescence models were constructed, replicative senescence (RS) and stress‑induced premature senescence (SIPS), using human heart mesenchymal stem cells (HMSCs). First, the differences in age‑related gene expression levels and telomere length were compared between the HMSCs in the RS and SIPS models by PCR. Subsequently, protein expression and the mitochondrial DNA (mtDNA) methylation status of cytochrome c oxidase subunit II (COX2) was measured by western blot analysis and bisulfite genomic sequencing (BSP). Finally, the value of the DNA methyltransferase (Dnmt) inhibitor, 5‑aza‑2'‑deoxycytidine (AdC), in delaying the senescence of HMSCs was evaluated. It was found that the p16, p27 and p53 mRNA expression levels increased in the senescent cells, whereas p21 mRNA expression did not. It was also found that telomere shortening only occurred in the RS model, but not in the SIPS model. Along with the senescence of HMSCs, COX2 gene methylation increased and its protein expression level significantly decreased. It was demonstrated that AdC inhibited COX2 methylation and downregulated COX2 expression. The addition of exogenous COX2 or the administration of AdC promoted cell proliferation and delayed cell aging. On the whole, the present study demonstrates that COX2 methylation and downregulation are biomarkers of HMSC senescence. Thus, COX2 may have potential for use as a therapeutic target of cardiovascular diseases and this warrants further investigation.
View Figures
View References

Related Articles

Journal Cover

January-2021
Volume 47 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Sun X, Wang Z, Cong X, Lv Y, Li Z, Rong L, Yang T and Yu D: Mitochondrial gene COX2 methylation and downregulation is a biomarker of aging in heart mesenchymal stem cells. Int J Mol Med 47: 161-170, 2021
APA
Sun, X., Wang, Z., Cong, X., Lv, Y., Li, Z., Rong, L. ... Yu, D. (2021). Mitochondrial gene COX2 methylation and downregulation is a biomarker of aging in heart mesenchymal stem cells. International Journal of Molecular Medicine, 47, 161-170. https://doi.org/10.3892/ijmm.2020.4799
MLA
Sun, X., Wang, Z., Cong, X., Lv, Y., Li, Z., Rong, L., Yang, T., Yu, D."Mitochondrial gene COX2 methylation and downregulation is a biomarker of aging in heart mesenchymal stem cells". International Journal of Molecular Medicine 47.1 (2021): 161-170.
Chicago
Sun, X., Wang, Z., Cong, X., Lv, Y., Li, Z., Rong, L., Yang, T., Yu, D."Mitochondrial gene COX2 methylation and downregulation is a biomarker of aging in heart mesenchymal stem cells". International Journal of Molecular Medicine 47, no. 1 (2021): 161-170. https://doi.org/10.3892/ijmm.2020.4799